Covered recipient · General Payments record
LILIBETH SALAZAR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$804.41
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.83 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $157.58 | 10 |
| Acerta Pharma LLC | $49.38 | 2 |
| DEXCOM, INC. | $23.06 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $27.91 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104276863 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.47 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104556614 | CMS |
| Dexcom, Inc. | $23.06 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374551 | CMS |
| Novo Nordisk Inc | $22.88 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100414966 | CMS |
| Novo Nordisk Inc | $6.10 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100335912 | CMS |
| Novo Nordisk Inc | $25.00 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100357038 | CMS |
| Novo Nordisk Inc | $17.36 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382379 | CMS |
| Novo Nordisk Inc | $4.37 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100476000 | CMS |
| Novo Nordisk Inc | $21.29 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100608582 | CMS |
| Novo Nordisk Inc | $22.29 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100386179 | CMS |
| Novo Nordisk Inc | $24.52 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100385089 | CMS |
| Novo Nordisk Inc | $5.46 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571960 | CMS |
| Novo Nordisk Inc | $8.31 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100606486 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.81 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151202587 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.